![Nick Flinn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Loopbaan van Nick Flinn
Eerdere bekende functies van Nick Flinn
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Incenta Ltd. | Corporate Officer/Principal | - | - |
Acambis Plc
![]() Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Corporate Officer/Principal | - | - |
MEDIVIR AB | Corporate Officer/Principal | - | - |
Amura Holdings Ltd.
![]() Amura Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amura Holdings Ltd. was engaged in drug discovery for diseases, such as osteoporosis, osteoarthritis, bone metastasis, autoimmunity, chronic pain, and malaria. The firm developed a technology platform that provided turnkey solutions for the discovery of small-molecule inhibitors against cysteine peptidases. The company was founded by Daniel James William Roach on June 6, 20005 and was headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | 25-07-2011 | - |
Opleiding van Nick Flinn
University of London | Undergraduate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 4 |
Letland | 2 |
Zweden | 2 |
Operationeel
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
MEDIVIR AB | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Amura Holdings Ltd.
![]() Amura Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amura Holdings Ltd. was engaged in drug discovery for diseases, such as osteoporosis, osteoarthritis, bone metastasis, autoimmunity, chronic pain, and malaria. The firm developed a technology platform that provided turnkey solutions for the discovery of small-molecule inhibitors against cysteine peptidases. The company was founded by Daniel James William Roach on June 6, 20005 and was headquartered in Cambridge, the United Kingdom. | Health Technology |
Acambis Plc
![]() Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
Incenta Ltd. |
- Beurs
- Insiders
- Nick Flinn
- Ervaring